TipRanks
Go Ultimate55% OFF

Anika Therapeutics (AKP) Revenue

0 Followers

Anika Therapeutics Revenue

Anika Therapeutics had a revenue of 32.61M in the quarter ending Jun 30, 2026, with 10.12%. This bring the company's revenue in the last twelve months to 120.65M, Increased 3.78%. In the fiscal year ending Dec 31, 2025, Anika Therapeutics had annual revenue of 112.82M with -5.91% growth.

Revenue (ttm)
120.65M
Revenue Growth
-9.02%
P/S Ratio
2.05
Revenue/Employee
EUR 480,081
Employees
235
Market Cap
EUR 231.09M

Revenue Chart

Anika Therapeutics Revenue - Annual

025M50M75M100M125M150M175M113.42M105.56M114.61M130.46M147.79M113.83M120.79M119.91M112.82M201720182019202020212022202320242025
Revenue History
Download to Excel
DE:AKP revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025112.82M-7.09M-5.91%
Dec 31, 2024119.91M-885.00K-0.73%
Dec 31, 2023120.79M6.96M6.12%
Dec 31, 2022113.83M-33.97M-22.98%
Dec 31, 2021147.79M17.34M13.29%
Dec 31, 2020130.46M15.85M13.83%
Dec 31, 2019114.61M9.05M8.58%
Dec 31, 2018105.56M-7.87M-6.93%
Dec 31, 2017113.42M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:AKP120.65M
RCEL75.63M
NSPR10.84M
XTNT109.53M
MODD0.00